These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1664827

  • 1. In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study.
    Finegold SM, Molitoris E, Reeves D, Wexler HM.
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():25-30. PubMed ID: 1664827
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of three of the newer quinolones against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):239-43. PubMed ID: 1317149
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.
    Wexler HM, Molitoris E, Reeves D, Finegold SM.
    J Antimicrob Chemother; 1994 Oct; 34(4):579-84. PubMed ID: 7868409
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of Bay Y3118 against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2509-13. PubMed ID: 8285647
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of DU-6859a against anaerobic bacteria.
    Wexler HM, Molitoris E, Reeves D, Finegold SM.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2504-9. PubMed ID: 7840599
    [Abstract] [Full Text] [Related]

  • 6. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
    Goldstein EJ, Citron DM.
    Antimicrob Agents Chemother; 1992 May; 36(5):1158-62. PubMed ID: 1324640
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of grepafloxacin (OPC-17116) against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):129-33. PubMed ID: 7805357
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
    Edlund C, Sabouri S, Nord CE.
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
    [Abstract] [Full Text] [Related]

  • 9. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
    King A, Bethune L, Phillips I.
    J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
    [Abstract] [Full Text] [Related]

  • 10. Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria.
    MacGowan AP, Bowker KE, Holt HA, Wootton M, Reeves DS.
    J Antimicrob Chemother; 1997 Oct; 40(4):503-9. PubMed ID: 9372419
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
    Nord CE.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S15-8. PubMed ID: 8953101
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
    Zabinski RA, Vance-Bryan K, Krinke AJ, Walker KJ, Moody JA, Rotschafer JC.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2454-8. PubMed ID: 8285633
    [Abstract] [Full Text] [Related]

  • 13. Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States.
    Goldstein EJ.
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S377-81. PubMed ID: 8324151
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of anaerobic bacteria to PD 131628.
    Nord CE, Hagelbäck A.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
    [Abstract] [Full Text] [Related]

  • 15. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A, Hardardottir H, Bottolfsen KL.
    Chemotherapy; 1991 Jan; 37(2):98-105. PubMed ID: 2032475
    [Abstract] [Full Text] [Related]

  • 16. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE, Lindmark A, Persson I.
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
    [Abstract] [Full Text] [Related]

  • 18. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2471-6. PubMed ID: 7840591
    [Abstract] [Full Text] [Related]

  • 19. Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.
    Hecht DW, Osmolski JR.
    Antimicrob Agents Chemother; 2003 Mar; 47(3):910-6. PubMed ID: 12604521
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes.
    Aldridge KE, Ashcraft D, Bowman KA.
    Antimicrob Agents Chemother; 1997 Feb; 41(2):484-7. PubMed ID: 9021215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.